UK markets closed
NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.02 +0.77 (+1.05%) GOLD FUTURES
2,374.80 +27.40 (+1.17%) DOW
38,783.50 +72.21 (+0.19%) Bitcoin GBP
55,754.18 +337.57 (+0.61%)
Pieris Pharmaceuticals, Inc. (PIRS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 13.60M |
| Enterprise value | -12.77M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.30 |
| Price/book (mrq) | 0.62 |
| Enterprise value/revenue | 1.76 |
| Enterprise value/EBITDA | -1.47 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.55 |
| 52-week change 3 | -85.24% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 80.80 |
| 52-week low 3 | 9.31 |
| 50-day moving average 3 | 12.12 |
| 200-day moving average 3 | 16.72 |
Share statistics
| Avg vol (3-month) 3 | 14.79k |
| Avg vol (10-day) 3 | 6.02k |
| Shares outstanding 5 | 1.32M |
| Implied shares outstanding 6 | 1.32M |
| Float 8 | 860.35k |
| % held by insiders 1 | 6.97% |
| % held by institutions 1 | 35.73% |
| Shares short (15 May 2024) 4 | 24.8k |
| Short ratio (15 May 2024) 4 | 1.08 |
| Short % of float (15 May 2024) 4 | 2.34% |
| Short % of shares outstanding (15 May 2024) 4 | 1.88% |
| Shares short (prior month 15 Apr 2024) 4 | 301 |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:80 |
| Last split date 3 | 23 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -39.71% |
| Operating margin (ttm) | -10,005.66% |
Management effectiveness
| Return on assets (ttm) | -6.30% |
| Return on equity (ttm) | -86.86% |
Income statement
| Revenue (ttm) | 40.93M |
| Revenue per share (ttm) | 34.04 |
| Quarterly revenue growth (yoy) | -97.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -3.86M |
| Net income avi to common (ttm) | -16.25M |
| Diluted EPS (ttm) | -11.40 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 19.08M |
| Total cash per share (mrq) | 14.45 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.92 |
| Book value per share (mrq) | 17.76 |
Cash flow statement
| Operating cash flow (ttm) | -49.82M |
| Levered free cash flow (ttm) | -32.18M |
© 2024 Yahoo. All rights reserved.